<code id='22C11D0149'></code><style id='22C11D0149'></style>
    • <acronym id='22C11D0149'></acronym>
      <center id='22C11D0149'><center id='22C11D0149'><tfoot id='22C11D0149'></tfoot></center><abbr id='22C11D0149'><dir id='22C11D0149'><tfoot id='22C11D0149'></tfoot><noframes id='22C11D0149'>

    • <optgroup id='22C11D0149'><strike id='22C11D0149'><sup id='22C11D0149'></sup></strike><code id='22C11D0149'></code></optgroup>
        1. <b id='22C11D0149'><label id='22C11D0149'><select id='22C11D0149'><dt id='22C11D0149'><span id='22C11D0149'></span></dt></select></label></b><u id='22C11D0149'></u>
          <i id='22C11D0149'><strike id='22C11D0149'><tt id='22C11D0149'><pre id='22C11D0149'></pre></tt></strike></i>

          entertainment

          entertainment

          author:explore    Page View:8876
          Cell and gene therapy sign seen at a conference. -- biotech coverage from STAT
          Jonathan Wosen for STAT

          CARLSBAD, Calif. — Biotech CEOs leading cell and gene therapy companies spoke frankly at a conference here last week about the tough choices they’re making to preserve limited cash amid the industry’s ongoing slowdown.

          The company leaders said that they’ve felt added pressure to use smaller teams to work quickly on fewer projects, and at times to partner with outside firms that have specific manufacturing and research expertise. Not all of these changes are bad, they added, noting that efficiency is a good trait for a biotech company in any market.

          advertisement

          The candid conversation on Thursday was part of Meeting on the Mesa, an annual cell and gene therapy conference held in Carlsbad, in the north of San Diego County. And it provided a glimpse into discussions happening across the life science industry as biotech markets continue a sharp slump that dates back to late 2021.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more
          Fetal surgery at risk from Dobbs and new abortion restrictions
          Fetal surgery at risk from Dobbs and new abortion restrictions

          AdobeTheconceptoffetalsurgerycapturestheimaginationwhen,fromtimetotime,itmakestheheadlines.Fewpregna

          read more
          Malaria cases in Florida and Texas: Here’s what you need to know
          Malaria cases in Florida and Texas: Here’s what you need to know

          MosquitoscaughtfortestingawaitshipmenttoalabinMcAllen,Texas,inApril2016tobetestedformosquito-bornedi

          read more

          Rep. Raul Ruiz on the physician shortage and more

          BeforehejoinedCongress,Rep.RaulRuiz,aDemocratfromCalifornia,workedinanotherchaoticenvironment:theeme